ALHC - Alignment Healthcare, Inc. Stock Price, Fair Value and News

7.25USD+0.26 (+3.72%)Market Closed

Market Summary

USD7.25+0.26

Market Closed

3.72%

ALHC Alerts

Big jump in Revenue (Y/Y)

Losses in recent quarter

ALHC Stock Price

View Fullscreen

ALHC RSI Chart

ALHC Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

-8.81

Price/Sales (Trailing)

0.69

EV/EBITDA

-11.55

Price/Free Cashflow

-16.79

ALHC Price/Sales (Trailing)

ALHC Profitability

EBT Margin

-7.82%

Return on Equity

-119.12%

Return on Assets

-24.83%

Free Cashflow Yield

-5.95%

ALHC Fundamentals

ALHC Revenue

Revenue (TTM)

2.0B

Rev. Growth (Yr)

43.14%

Rev. Growth (Qtr)

35.07%

ALHC Earnings

Earnings (TTM)

-157.3M

Earnings Growth (Yr)

-24.77%

Earnings Growth (Qtr)

1.46%

Breaking Down ALHC Revenue

Last 7 days

6.2%

Last 30 days

46.5%

Last 90 days

9.2%

Trailing 12 Months

9.2%

How does ALHC drawdown profile look like?

ALHC Financial Health

Current Ratio

1.57

Debt/Equity

1.23

Debt/Cashflow

-0.93

ALHC Investor Care

Shares Dilution (1Y)

1.50%

Diluted EPS (TTM)

-0.84

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.0B	0	0	0
2023	1.5B	1.6B	1.7B	1.8B
2022	1.2B	1.3B	1.4B	1.4B
2021	1.0B	1.1B	1.1B	1.2B
2020	807.5M	858.1M	908.7M	959.2M
2019	0	0	0	757.0M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Alignment Healthcare, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 28, 2024	scavo robert l.	sold	-8,813	4.84	-1,821	chief information officer
Mar 28, 2024	maroney dawn christine	sold	-49,130	4.84	-10,151	president, markets
Mar 28, 2024	freeman robert thomas	sold	-20,807	4.84	-4,299	chief financial officer
Mar 28, 2024	kardes hakan	sold	-21,116	4.84	-4,363	chief experience officer
Mar 20, 2024	maroney dawn christine	sold	-64,007	4.83	-13,252	president, markets
Mar 19, 2024	kim hyong	sold	-28,163	5.0508	-5,576	chief medical officer
Mar 19, 2024	maroney dawn christine	sold	-80,110	5.0508	-15,861	president, markets
Mar 19, 2024	joyce christopher j	sold	-126,573	5.0508	-25,060	chief legal and admin. officer
Mar 19, 2024	scavo robert l.	sold	-15,546	5.0508	-3,078	chief information officer
Mar 19, 2024	freeman robert thomas	sold	-144,059	5.0508	-28,522	chief financial officer

Which funds bought or sold ALHC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-3.98	-408,959	506,267	-%
May 16, 2024	JANE STREET GROUP, LLC	reduced	-35.75	-590,018	346,733	-%
May 16, 2024	COMERICA BANK	sold off	-100	-1,584	-	-%
May 15, 2024	PDT Partners, LLC	reduced	-77.45	-713,910	106,580	0.01%
May 15, 2024	Cresset Asset Management, LLC	added	0.01	-1,079,340	1,467,010	0.01%
May 15, 2024	ALGERT GLOBAL LLC	unchanged	-	-222,000	301,000	0.01%
May 15, 2024	Concorde Asset Management, LLC	added	146	82,977	280,835	0.19%
May 15, 2024	Brevan Howard Capital Management LP	new	-	94,736	94,736	-%
May 15, 2024	ADAGE CAPITAL PARTNERS GP, L.L.C.	new	-	1,686,400	1,686,400	-%
May 15, 2024	PRELUDE CAPITAL MANAGEMENT, LLC	new	-	54,064	54,064	-%

Are Funds Buying or Selling ALHC?

Are funds buying ALHC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ALHC

No. of Funds

Unveiling Alignment Healthcare, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	t. rowe price investment management, inc.	6.4%	12,075,504	SC 13G
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Feb 13, 2023	general atlantic, l.p.	32.6%	60,993,323	SC 13G/A
Feb 10, 2023	warburg pincus private equity xii, l.p.	6.16%	11,544,243	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 14, 2022	warburg pincus private equity xii, l.p.	7.8%	14,665,604	SC 13G
Feb 11, 2022	general atlantic, l.p.	37.4%	70,069,317	SC 13G
Feb 09, 2022	fmr llc	-	0	SC 13G

Recent SEC filings of Alignment Healthcare, Inc.

View All Filings

Date Filed	Form Type	Document
May 17, 2024	SC 13G	Major Ownership Report
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
Apr 26, 2024	ARS	ARS
Apr 26, 2024	DEF 14A	DEF 14A
Apr 26, 2024	DEFA14A	DEFA14A
Apr 12, 2024	PRE 14A	PRE 14A
Mar 29, 2024	4	Insider Trading
Mar 29, 2024	4	Insider Trading
Mar 29, 2024	4	Insider Trading

Peers (Alternatives to Alignment Healthcare, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	482.9B	379.5B	9.53%	9.48%	31.44	1.27	12.96%	-25.81%
CI	96.2B	206.0B	-2.11%	32.08%	24.97	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	3.80%	15.55%	15.46	1.27	9.59%	-4.59%
CVS	72.4B	360.9B	-15.92%	-16.78%	9.89	0.2	9.07%	78.49%
CNC	41.7B	155.5B	8.44%	18.66%	15.24	0.27	6.34%	84.42%
DVA	12.3B	12.3B	9.53%	38.52%	15.03	0.99	5.77%	58.74%
UHS	11.9B	14.7B	11.04%	30.82%	14.63	0.81	7.99%	19.23%
MID-CAP
CHE	8.5B	2.3B	-6.47%	5.37%	30.15	3.73	5.96%	18.29%
ACHC	6.2B	3.0B	-5.49%	-7.73%	-545.12	2.06	10.92%	-104.06%
AMEH	2.3B	1.5B	9.06%	20.53%	36.62	1.57	19.34%	40.15%
AMN	2.2B	3.5B	4.01%	-38.44%	15.49	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	14.53%	25.72%	27.59	1.67	11.45%	30.74%
BKD	1.3B	3.0B	6.97%	85.25%	-7.66	0.44	4.98%	4.88%
BEAT	54.5M	-	-4.17%	-6.33%	-3.61	-	-	-1.05%
AMS	22.0M	21.6M	16.05%	23.93%	39.79	1.02	9.04%	-50.63%

Alignment Healthcare, Inc. News

Latest updates

Alignment Healthcare, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Revenue	35.1%	628,601,000	465,387,000	456,709,000	462,379,000	439,155,000	361,811,000	360,348,000	366,474,000	345,526,000	298,274,000	293,466,000	308,951,000	267,082,000	242,409,000	247,867,000	244,313,000	224,633,000	-
Operating Expenses	32.0%	669,707,000	507,300,000	486,465,000	486,038,000	471,644,000	413,917,000	393,758,000	373,122,000	382,001,000	341,740,000	334,916,000	349,443,000	319,746,000	270,204,000	232,807,000	231,726,000	229,748,000	-
S&GA Expenses	8.1%	90,512,000	83,737,000	83,089,000	70,199,000	70,408,000	83,228,000	76,452,000	61,673,000	74,293,000	78,081,000	76,846,000	71,150,000	64,914,000	51,119,000	38,794,000	33,698,000	32,787,000	-
EBITDA Margin	2.7%	-0.06	-0.06	-0.07	-0.08	-0.07	-0.08	-0.08	-0.09	-0.12	-0.14	-0.13	-0.08	-	-	-	-	-	-
Interest Expenses	-1.0%	5,427,000	5,484,000	5,466,000	5,262,000	5,019,000	4,793,000	4,605,000	4,490,000	4,401,000	4,452,000	4,414,000	4,329,000	4,248,000	4,308,000	4,271,000	4,192,000	4,160,000	-
Income Taxes	100.0%	-	-24,000	-	1,000	1,000	172,000	167,000	-	-	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	1.4%	-46,575,000	-47,255,000	-35,077,000	-28,493,000	-37,370,000	-56,823,000	-40,080,000	-11,580,000	-40,817,000	-47,834,000	-45,816,000	-44,762,000	-56,874,000	-32,065,000	10,846,000	8,365,000	-10,072,000	-
EBT Margin	3.8%	-0.08	-0.08	-0.09	-0.10	-0.10	-0.10	-0.10	-0.11	-0.14	-0.17	-0.16	-0.12	-	-	-	-	-	-
Net Income	1.5%	-46,521,000	-47,209,000	-35,047,000	-28,477,000	-37,284,000	-56,903,000	-40,247,000	-11,580,000	-40,817,000	-47,834,000	-45,816,000	-44,762,000	-56,874,000	-32,065,000	10,846,000	8,365,000	-10,072,000	-
Net Income Margin	3.8%	-0.08	-0.08	-0.09	-0.10	-0.10	-0.10	-0.10	-0.11	-0.14	-0.17	-0.16	-0.12	-	-	-	-	-	-
Free Cashflow	-Infinity%	-17,359,000	-	-1,293,000	29,892,000	77,825,000	-	-	-	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet															(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2019Q4
Assets	7.0%	633	592	771	784	762	634	778	667	647	631	657	670	679	339	193
Current Assets	7.7%	521	484	667	684	671	545	692	586	566	553	577	593	605	265	127
Cash Equivalents	18.8%	241	203	392	395	384	410	567	453	449	467	500	495	528	208	86.00
Net PPE	10.2%	57.00	52.00	47.00	43.00	40.00	37.00	36.00	33.00	32.00	30.00	32.00	30.00	28.00	27.00	27.00
Goodwill	0%	35.00	35.00	-	-	-	35.00	-	-	-	-	-	-	-	-	-
Liabilities	15.5%	501	434	581	572	538	395	505	373	353	325	332	330	325	308	272
Current Liabilities	25.7%	331	263	410	402	374	230	340	214	195	167	175	174	170	153	130
Long Term Debt	0.1%	162	162	162	161	161	161	161	154	152	151	149	147	146	144	138
LT Debt, Non Current	-100.0%	-	162	162	161	161	161	161	154	152	151	149	147	146	144	138
Shareholder's Equity	-15.9%	132	157	189	211	224	238	272	294	293	306	325	340	354	31.00	79.00
Retained Earnings	-5.3%	-926	-880	-833	-798	-769	-732	-675	-635	-623	-582	-527	-481	-436	-379	-78.71
Additional Paid-In Capital	2.0%	1,058	1,037	1,021	1,008	992	970	947	929	917	889	852	821	791	410	-
Shares Outstanding	1.2%	191	189	189	189	188	187	187	187	187	187	187	187	-	-	-
Minority Interest	-3.5%	1.00	1.00	1.00	1.00	1.00	1.00	-	-	0.00	0.00	0.00	0.00	-	-	-
Float	-	-	-	-	675	-	-	-	950	-	-	-	1,321	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																		(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Cashflow From Operations	96.7%	-6,238	-187,466	5,992	37,177	85,110	-149,263	105,120	10,354	-11,638	-30,134	12,914	-23,449	-38,107	-10,146	26,039	13,487	-21,819	-
Share Based Compensation	33.2%	20,854	15,652	13,569	15,636	21,978	22,885	18,687	12,099	28,047	28,814	30,511	30,887	31,787	1,144	304	350	326	-
Cashflow From Investing	4295.0%	42,705	-1,018	-9,607	-26,210	-110,428	-8,107	-8,128	-5,855	-6,127	-2,951	-6,997	-6,421	-4,446	-4,725	-4,258	-3,640	-3,735	-
Cashflow From Financing	-844.4%	-335	45.00	-	30.00	30.00	-527	17,220	-100	-	-	-	-3,529	363,659	-144	-338	-878	131,484	-
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	1,474	144	338	507	516	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

ALHC Income Statement

2024-03-31

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Earned premiums	$ 621,556	$ 434,812
Other	7,045	4,343
Total revenues	628,601	439,155
Expenses:
Medical expenses	573,218	396,315
Selling, general, and administrative expenses	90,512	70,408
Depreciation and amortization	5,977	4,921
Total expenses	669,707	471,644
Loss from operations	(41,106)	(32,489)
Other expenses:
Interest expense	5,427	5,019
Other expenses (income)	42	(138)
Total other expenses	5,469	4,881
Loss before income taxes	(46,575)	(37,370)
Provision for income taxes	0	1
Net loss	(46,575)	(37,371)
Less: Net loss attributable to noncontrolling interest	54	87
Net loss attributable to Alignment Healthcare, Inc.	$ (46,521)	$ (37,284)
Total weighted-average common shares outstanding, net of restricted shares of common stock - basic (in shares)	189,005,394	183,113,945
Total weighted-average common shares outstanding, net of restricted shares of common stock - diluted (in shares)	189,005,394	183,113,945
Net loss per share - basic (in dollars per share)	$ (0.25)	$ (0.20)
Net loss per share - diluted (in dollars per share)	$ (0.25)	$ (0.20)

ALHC Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 238,903	$ 202,904
Accounts receivable (less allowance for credit losses of $0 at March 31, 2024 and December 31, 2023)	165,071	119,749
Investments - current	62,809	115,914
Prepaid expenses and other current assets	53,856	44,970
Total current assets	520,639	483,537
Property and equipment, net	57,211	51,901
Right of use asset, net	8,549	9,959
Goodwill	34,826	34,826
Intangible Assets, net	5,224	5,252
Other assets	6,781	6,405
Total assets	633,230	591,880
Current Liabilities:
Medical expenses payable	276,464	205,399
Accounts payable and accrued expenses	22,671	23,511
Accrued compensation	31,607	34,112
Total current liabilities	330,742	263,022
Long-term debt, net of debt issuance costs	162,030	161,813
Long-term portion of lease liabilities	8,441	8,974
Total liabilities	501,213	433,809
Commitments and Contingencies (Note 12)
Stockholders' Equity:
Preferred stock, $.001 par value; $100,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of March 31, 2024 and December 31, 2023	0	0
Common stock, $.001 par value; $1,000,000,000 shares authorized as of March 31, 2024 and December 31, 2023; $191,156,569 and $188,951,643 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	191	189
Additional paid-in capital	1,057,519	1,037,015
Accumulated deficit	(926,779)	(880,258)
Total Alignment Healthcare, Inc. stockholders' equity	130,931	156,946
Noncontrolling interest	1,086	1,125
Total stockholders' equity	132,017	158,071
Total liabilities and stockholders' equity	$ 633,230	$ 591,880

About Alignment Healthcare, Inc.

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, Nevada, Arizona, Florida, and Texas. The company was founded in 2013 and is based in Orange, California.

CEO	Mr. John E. Kao
WEBSITE	alignmenthealthcare.com
INDUSTRY	Healthcare Plans
EMPLOYEES	1037

Alignment Healthcare, Inc. Frequently Asked Questions

What is the ticker symbol for Alignment Healthcare, Inc.? What does ALHC stand for in stocks?

ALHC is the stock ticker symbol of Alignment Healthcare, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Alignment Healthcare, Inc. (ALHC)?

As of Fri May 17 2024, market cap of Alignment Healthcare, Inc. is 1.39 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ALHC stock?

You can check ALHC's fair value in chart for subscribers.

What is the fair value of ALHC stock?

You can check ALHC's fair value in chart for subscribers. The fair value of Alignment Healthcare, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Alignment Healthcare, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ALHC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Alignment Healthcare, Inc. a good stock to buy?

The fair value guage provides a quick view whether ALHC is over valued or under valued. Whether Alignment Healthcare, Inc. is cheap or expensive depends on the assumptions which impact Alignment Healthcare, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ALHC.

What is Alignment Healthcare, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, ALHC's PE ratio (Price to Earnings) is -8.81 and Price to Sales (PS) ratio is 0.69. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ALHC PE ratio will change depending on the future growth rate expectations of investors.